{"doi":"10.1016/j.jocn.2009.06.003","title":"Introduction of intravenous formulations of the antiepileptic drugs levetiracetam and valproate to the Australian market","abstract":null,"journal":"Journal of Clinical Neuroscience","year":2009,"id":26605,"datarank":0.10397207708399181,"base_score":0.6931471805599453,"endowment":0.6931471805599453,"self_citation_contribution":0.10397207708399181,"citation_network_contribution":0.0,"self_endowment_contribution":0.10397207708399181,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":1,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":153535,"name":"Frank J.E. Vajda","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"19804975","pmcid":null,"openalex_id":"https://openalex.org/W19804975","authors":[],"funders":[],"total_grants":0,"fwci":0.0,"citation_percentile":0.00329128,"influential_citations":0,"citation_trend":[],"oa_status":"closed","license":"https://www.elsevier.com/legal/tdmrep-license","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S0967586809003646?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0967586809003646?httpAccept=text/plain","host_type":"publisher"},{"url":"http://www.osti.gov/scitech/biblio/4803310","host_type":"repository"}],"fields_of_study":["Nuclear reactor physics and engineering","Graphite, nuclear technology, radiation studies","Radiation Effects and Dosimetry","Medicine","Anticonvulsants","Australia","Epilepsy","Humans","Injections, Intravenous","Marketing of Health Services","Valproic Acid"],"mesh_terms":["Humans","Epilepsy","Valproic Acid","Anticonvulsants","Injections, Intravenous","Marketing of Health Services","Australia"],"keywords":["Transition (genetics)","Physics","Chemistry"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Reduced inequalities"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-08T15:00:33.771484Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}